Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase

Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons, Chu-Chiao Wu, Melissa A. Hoffman, Aaron N. Snead, Xiaodan Song, Thomas Glaza, Shota Kikuchi, Jason C. Green, Donald C. Rogness, Betty Lam, Maria E. Rodriguez-Aguirre, David R. Woody, Christie L. Eissler, Socorro Rodiles, Seth M. Negron, Steffen M. Bernard, Eileen Tran, Jonathan Pollock, Ali Tabatabaei, Victor Contreras, Heather N. Williams, Martha K. Pastuszka, John J. Sigler, Piergiorgio Pettazzoni, Markus G. Rudolph, Moritz Classen, Doris Brugger, Christopher Claiborne, Jean-Marc Plancher, Isabel Cuartas, Joan Seoane, Laurence E. Burgess, Robert T. Abraham, David S. Weinstein, Gabriel M. Simon, Matthew P. Patricelli () and Todd M. Kinsella ()
Additional contact information
Kristen A. Baltgalvis: Vividion Therapeutics
Kelsey N. Lamb: Vividion Therapeutics
Kent T. Symons: Vividion Therapeutics
Chu-Chiao Wu: Vividion Therapeutics
Melissa A. Hoffman: Vividion Therapeutics
Aaron N. Snead: Vividion Therapeutics
Xiaodan Song: Vividion Therapeutics
Thomas Glaza: Vividion Therapeutics
Shota Kikuchi: Vividion Therapeutics
Jason C. Green: Vividion Therapeutics
Donald C. Rogness: Vividion Therapeutics
Betty Lam: Vividion Therapeutics
Maria E. Rodriguez-Aguirre: Vividion Therapeutics
David R. Woody: Vividion Therapeutics
Christie L. Eissler: Vividion Therapeutics
Socorro Rodiles: Vividion Therapeutics
Seth M. Negron: Vividion Therapeutics
Steffen M. Bernard: Vividion Therapeutics
Eileen Tran: Vividion Therapeutics
Jonathan Pollock: Vividion Therapeutics
Ali Tabatabaei: Vividion Therapeutics
Victor Contreras: Vividion Therapeutics
Heather N. Williams: Vividion Therapeutics
Martha K. Pastuszka: Vividion Therapeutics
John J. Sigler: Vividion Therapeutics
Piergiorgio Pettazzoni: Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd
Markus G. Rudolph: Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd
Moritz Classen: Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd
Doris Brugger: Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd
Christopher Claiborne: Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd
Jean-Marc Plancher: Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd
Isabel Cuartas: CIBERONC
Joan Seoane: CIBERONC
Laurence E. Burgess: Vividion Therapeutics
Robert T. Abraham: Vividion Therapeutics
David S. Weinstein: Vividion Therapeutics
Gabriel M. Simon: Vividion Therapeutics
Matthew P. Patricelli: Vividion Therapeutics
Todd M. Kinsella: Vividion Therapeutics

Nature, 2024, vol. 631, issue 8021, E12-E12

Date: 2024
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41586-024-07595-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:631:y:2024:i:8021:d:10.1038_s41586-024-07595-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-024-07595-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().